Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Παρόμοια τεκμήρια

• Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.
  ανά: Gollapudi, S V, κ.ά.
  Έκδοση: (1988)
• Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.
  ανά: Gollapudi, S V, κ.ά.
  Έκδοση: (1986)
• In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
  ανά: Thadepalli, H, κ.ά.
  Έκδοση: (1997)
• Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
  ανά: Bansal, M B, κ.ά.
  Έκδοση: (1987)
• In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
  ανά: Stamm, J M, κ.ά.
  Έκδοση: (1986)